Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer

被引:4
|
作者
Laan, Janna [1 ,2 ]
van Lonkhuijzen, Luc [2 ,3 ]
Hinnen, Karel [1 ]
Pieters, Bradley [1 ,2 ]
Dekker, Inge [4 ]
Stalpers, Lukas [1 ,2 ]
Westerveld, Henrike [1 ,5 ]
机构
[1] Locat Univ Amsterdam, Dept Radiat Oncol, Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Canc Treatment & Qual Life, Amsterdam, Netherlands
[3] Locat Univ Amsterdam, Dept Gynecol, Amsterdam UMC, Amsterdam, Netherlands
[4] Locat VUmc, Dept Nutr & Dietet, Amsterdam UMC, Amsterdam, Netherlands
[5] Erasmus MC, Dept Radiotherapy, Rotterdam, Netherlands
关键词
Uterine Cervical Neoplasms; Radiotherapy; Radiation Oncology; BODY-MASS INDEX; RISK-FACTORS; WEIGHT-LOSS; PREVALENCE; CARCINOMA; TOXICITY; OUTCOMES; ALCOHOL;
D O I
10.1136/ijgc-2023-005024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCancer patients are at risk of malnutrition, which is associated with poor oncological outcomes. The aim of this study was to assess the incidence of malnutrition before, during, and after radiotherapy in locally advanced cervical cancer patients. In addition, we evaluated the impact of malnutrition on survival, and whether and when malnourished patients were referred to a dietitian.MethodsThis retrospective cohort study included cervical cancer patients who received primary or adjuvant radiotherapy with curative intent between January 2013 and January 2021. Patient and treatment characteristics, including longitudinal data on weight and dietary care, were retrieved from the electronic patient files. Malnutrition was defined by body mass index and weight loss according to the Global Leadership Initiative on Malnutrition (GLIM). Overall survival was estimated using the Kaplan-Meier method. Cox proportional hazard regression analysis was used to estimate hazard ratios for key prognostic factors.ResultsA total of 294 patients were included. Median follow-up was 40 months (range 7-101 months). Malnutrition occurred in 44 patients (15%) at baseline, in 132 (45%) during radiotherapy, and in 63 (21%) during follow-up. Referral to a dietician occurred in 45% of the 138 patients who were malnourished before or during radiotherapy. Malnutrition was significantly associated with worse survival after adjusting for age, performance score, diabetes, histology, International Federation of Gynecology and Obstetrics (FIGO) stage, and nodal stage. The 3 year overall survival in patients with malnutrition was 77% (95% confidence interval (CI) 70% to 85%) and without malnutrition 89% (95% CI 83% to 95%); p=0.001). Independent significant risk factors for worse overall survival were: malnutrition, age >52 years, adenocarcinoma, FIGO stage III/IV, and N1 disease.ConclusionMalnutrition was common in cervical cancer patients treated with radiotherapy and was associated with a shorter overall survival. Further studies are needed to evaluate the effectiveness of better monitoring of malnutrition and faster and better dietary intervention on survival and quality of life.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 50 条
  • [41] Prevention of vaginal agglutination by women treated with radiotherapy for cervical cancer
    Hansen, AH
    Fruerlund, L
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S22 - S22
  • [42] Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer
    Xiang, Michael
    Kidd, Elizabeth A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (08): : 969 - +
  • [43] Definitive Radiotherapy with or Without Cisplatin for Cervical Cancer in Older Women
    Xiang, Michael
    Kidd, Elizabeth
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E11 - E11
  • [44] Sexual Experience of Women After Pelvic Radiotherapy for Cervical Cancer
    Aydin, Reyhan
    Oskay, Umran Yesiltepe
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2016, 31 (04): : 119 - 127
  • [45] Sociodemographic characteristics and their association with survival in women with cervical cancer
    Lucely Cetina-Pérez
    Julissa Luvián-Morales
    Merari Delgadillo-González
    Denisse Castro-Eguiluz
    Tatiana Galicia-Carmona
    Kely Rely
    Rita Vaca González
    Gabriela Lugo-Martínez
    Nadia García-Barrientos
    Antonio Nateras
    BMC Cancer, 24
  • [46] Sociodemographic characteristics and their association with survival in women with cervical cancer
    Cetina-Perez, Lucely
    Luvian-Morales, Julissa
    Delgadillo-Gonzalez, Merari
    Castro-Eguiluz, Denisse
    Galicia-Carmona, Tatiana
    Rely, Kely
    Vaca Gonzalez, Rita
    Lugo-Martinez, Gabriela
    Garcia-Barrientos, Nadia
    Nateras, Antonio
    BMC CANCER, 2024, 24 (01)
  • [47] HIV Infection and Survival Among Women With Cervical Cancer
    Dryden-Peterson, Scott
    Bvochora-Nsingo, Memory
    Suneja, Gita
    Efstathiou, Jason A.
    Grover, Surbhi
    Chiyapo, Sebathu
    Ramogola-Masire, Doreen
    Kebabonye-Pusoentsi, Malebogo
    Clayman, Rebecca
    Mapes, Abigail C.
    Tapela, Neo
    Asmelash, Aida
    Medhin, Heluf
    Viswanathan, Akila N.
    Russell, Anthony H.
    Lin, Lilie L.
    Kayembe, Mukendi K. A.
    Mmalane, Mompati
    Randall, Thomas C.
    Chabner, Bruce
    Lockman, Shahin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3749 - +
  • [48] Low Survival Rates in Kenyan Women With Cervical Cancer
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23): : 2497 - 2497
  • [49] The sexuality of women with cervical cancer undergoing definitive radiotherapy in Ghana
    Kyei, K. A.
    Daniels, J.
    Broni, R.
    Anim-Sampong, S.
    Kitson-Mills, D.
    Amoabeng, K. A.
    Tackie, J. N. Odey
    Obeng-Mensah, T.
    Scott, P. A. Anoa
    Owusu, A. -B.
    RADIOGRAPHY, 2024, 30 (01) : 332 - 339
  • [50] Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer
    Yang, Li
    Xu, Zhiyuan
    Ma, Lingyu
    Liu, Qin
    Chang, Amy T. Y.
    Wang, Qian
    Zha, Jiandong
    Zhang, Jinliang
    Jiang, Xiaoqin
    Zhang, Jingjing
    Kong, Feng-Ming
    Guo, Linlang
    CANCER BIOMARKERS, 2022, 34 (01) : 149 - 159